Transauricular Neurostimulation for Abdominal Pain Due to DGBI
A legfontosabb adatok
- Hol
- Columbus (Egyesült Államok)A helyszín megnézése
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 12 és 18 év között vagy?
Forrás: NCT07798180: ki vehet részt
Helyszínek itt: Egyesült Államok
- Nationwide Children's HospitalColumbus, Egyesült ÁllamokContact: Peter Lu, MDRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Nationwide Children's Hospital
- Azonosító
- NCT07798180
- A regiszteradat frissítve
- 2026. szeptember 1.
- Eredeti leírás
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.A teljes eredeti leírásKevesebb
Transauricular Neurostimulation for Irritable Bowel Syndrome
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.
Bevonási feltételek: Age 12-18 years; Clinical diagnosis of an abdominal pain-related disorder of gut-brain interaction (DGBI) meeting Rome IV criteria; Average abdominal pain intensity ≥3 on a 0-10 scale and pain on at least 2 days per week; Proper fit of the Sparrow earpiece on the left ear, as determined by study personnel.
Kizáró feltételek: Change in medications used to treat abdominal pain or gastrointestinal symptoms within 2 weeks before enrollment. Participants must be on stable doses for at least 2 weeks before enrollment; Medical or psychiatric condition that contraindicates transauricular neurostimulation or creates a safety risk; Abnormal ear anatomy preventing earpiece placement; Developmental delay; Implanted electronic device or hearing aid; Participation in another interventional trial; Pregnancy; Unable to communicate in English; Prisoner.